Ground Zero Pharmaceuticals
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Spectrum Center Dr Ste 900, Irvine, ...Phone Number
(949) 419-6136Website
www.groundzerous.comRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ground Zero Pharmaceuticals
Ground Zero Pharmaceuticals, Inc. (GZP) focuses on bringing medical product programs through the FDA regulatory process, from late discovery through final approval and postmarketing. GZPs philosophy of doing what is necessary and sufficient and no more at each stage of development aids clients via clean, cost-effective, targeted and accelerated development plans. With emphasis on completing each portion of a product's lifecycle in a rapid and resource sparing manner, while maintaining acceptable quality for FDA review, GZP adds value to the company's client programs by enabling accomplishment of important milestones.Explore more
Ground Zero Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ground Zero Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Ground Zero Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Ground Zero Pharmaceuticals
Product Launch: Get notified when Ground Zero Pharmaceuticals launches new products
Click to see if Ground Zero Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Ground Zero Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Ground Zero Pharmaceuticals has new funding data
Ground Zero Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Ground Zero Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Ground Zero Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Ground Zero Pharmaceuticals
Compare insights from companies similar to Ground Zero Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ground Zero Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ground Zero Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ground Zero Pharmaceuticals.
Ground Zero Pharmaceuticals financials insights
Gather financial insights about Ground Zero Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$194K
Ground Zero Pharmaceuticals Tech Stack
A closer look at the technologies used by Ground Zero Pharmaceuticals
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ground Zero Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Ground Zero Pharmaceuticals, Inc. (GZP) focuses on bringing medical product programs through the FDA regulatory process, from late discovery through final approval and postmarketing. GZPs philosophy of doing what is necessary and sufficient and no more at each stage of development aids clients via clean, cost-effective, targeted and accelerated dev... Read More
